Eugene Schneider - Net Worth and Insider Trading
Eugene Schneider Net Worth
The estimated net worth of Eugene Schneider is at least $2 Million dollars as of 2024-11-13. Eugene Schneider is the EVP, Chf Clinical Develop Ofcr of Ionis Pharmaceuticals Inc and owns about 49,812 shares of Ionis Pharmaceuticals Inc (IONS) stock worth over $2 Million. Details can be seen in Eugene Schneider's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eugene Schneider has not made any transactions after 2024-02-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eugene Schneider
Eugene Schneider Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eugene Schneider owns 1 companies in total, including Ionis Pharmaceuticals Inc (IONS) .
Click here to see the complete history of Eugene Schneider’s form 4 insider trades.
Insider Ownership Summary of Eugene Schneider
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IONS | Ionis Pharmaceuticals Inc | 2024-02-02 | EVP & Chf Clinical Develop Offc |
Eugene Schneider Latest Holdings Summary
Eugene Schneider currently owns a total of 1 stock. Eugene Schneider owns 49,812 shares of Ionis Pharmaceuticals Inc (IONS) as of February 2, 2024, with a value of $2 Million.
Latest Holdings of Eugene Schneider
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IONS | Ionis Pharmaceuticals Inc | 2024-02-02 | 49,812 | 37.77 | 1,881,399 |
Holding Weightings of Eugene Schneider
Eugene Schneider Form 4 Trading Tracker
According to the SEC Form 4 filings, Eugene Schneider has made a total of 7 transactions in Ionis Pharmaceuticals Inc (IONS) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Ionis Pharmaceuticals Inc is the sale of 2,071 shares on February 2, 2024, which brought Eugene Schneider around $102,701.
Insider Trading History of Eugene Schneider
- 1
Eugene Schneider Trading Performance
Eugene Schneider Ownership Network
Ownership Network List of Eugene Schneider
Ownership Network Relation of Eugene Schneider
Eugene Schneider Owned Company Details
What does Ionis Pharmaceuticals Inc do?
Who are the key executives at Ionis Pharmaceuticals Inc?
Eugene Schneider is the EVP & Chf Clinical Develop Offc of Ionis Pharmaceuticals Inc. Other key executives at Ionis Pharmaceuticals Inc include SVP & Research Eric Swayze , Senior Vice President Richard S Geary , and EVP & Corp and Development Ops Brian Birchler .
Ionis Pharmaceuticals Inc (IONS) Insider Trades Summary
Over the past 18 months, Eugene Schneider made 5 insider transaction in Ionis Pharmaceuticals Inc (IONS) with a net sale of 42,659. Other recent insider transactions involving Ionis Pharmaceuticals Inc (IONS) include a net sale of 181,397 shares made by Brett P Monia , a net sale of 35,600 shares made by Richard S Geary , and a net sale of 60,168 shares made by C Frank Bennett .
In summary, during the past 3 months, insiders sold 704 shares of Ionis Pharmaceuticals Inc (IONS) in total and bought 0 shares, with a net sale of 704 shares. During the past 18 months, 614,196 shares of Ionis Pharmaceuticals Inc (IONS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 614,196 shares.
Ionis Pharmaceuticals Inc (IONS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ionis Pharmaceuticals Inc Insider Transactions
Eugene Schneider Mailing Address
Above is the net worth, insider trading, and ownership report for Eugene Schneider. You might contact Eugene Schneider via mailing address: C/o Ionis Pharmaceuticals, 2855 Gazelle Ct, Carlsbad Ca 92010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
